Product Information
DROSPIRENONE-EE 3-0.03 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1511 per EA under NDC 68180086873. Its NADAC has been published 210 times since Sep 28, 2022.
FDA first approved this application on Dec 18, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180086873
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201663FDA Approved
12/18/2012
TE Code
AB
On Market Since
4/15/2022
Price Statistics
The NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has been published 210 times since Sep 28, 2022, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1511 per EA |
|---|---|
| All-time high | $0.2248 (Nov 16, 2022) |
| All-time low | $0.1445 (Jul 22, 2026) |
| 52-week high | $0.1731 |
| 52-week low | $0.1445 |
| Median price | $0.1757 |
| Average price | $0.1766 |
| Largest weekly change | +27.6% (Jun 19, 2024) |
| Weeks tracked | 210 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DROSPIRENONE AND ETHINYL ESTRADIOL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DROSPIRENONE AND ETHINYL ESTRADIOL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DROSPIRENONE-EE 3-0.03 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DROSPIRENONE-EE 3-0.03 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.1511 per EA (NDC 68180086873), effective Sep 30, 2026.
How has the price of DROSPIRENONE-EE 3-0.03 MG TAB changed over time?
Over the history we have for it, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has declined 28.7%. It has been tracked across 210 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for DROSPIRENONE-EE 3-0.03 MG TAB?
Since Sep 28, 2022, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has ranged from a low of $0.1445 (Jul 22, 2026) to a high of $0.2248 (Nov 16, 2022), with a median of $0.1757 per EA.
Are there cheaper alternatives to DROSPIRENONE-EE 3-0.03 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DROSPIRENONE-EE 3-0.03 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DROSPIRENONE-EE 3-0.03 MG TAB?
DROSPIRENONE-EE 3-0.03 MG TAB (NDC 68180086873) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.